The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson’s disease

BACKGROUND: It is suggested that neuroinflammation, in which activated microglial cells play a relevant role, contributes to the development of Parkinson’s disease (PD). Consequently, the modulation of microglial activation is a potential therapeutic target to be taken into account to act against th...

Descripción completa

Detalles Bibliográficos
Autores principales: Rabaneda-Lombarte, Neus, Serratosa, Joan, Bové, Jordi, Vila, Miquel, Saura, Josep, Solà, Carme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025338/
https://www.ncbi.nlm.nih.gov/pubmed/33823877
http://dx.doi.org/10.1186/s12974-021-02132-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025338/
https://www.ncbi.nlm.nih.gov/pubmed/33823877
http://dx.doi.org/10.1186/s12974-021-02132-z

Ejemplares similares